Verano Holdings Corp. Reports Q3 Loss, Lags Revenue Estimates
| ICUI Stock | USD 171.96 2.85 1.63% |
Under 62% of ICU Medical's investor base is looking to short. The analysis of overall sentiment of trading ICU Medical stock suggests that many investors are alarmed at this time. ICU Medical's investing sentiment shows overall attitude of investors towards ICU Medical.
ICU |
Verano Holdings Corp. delivered earnings and revenue surprises of -300 percent and 4.39, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Read at finance.yahoo.com
 |
ICU Medical Fundamental Analysis
We analyze ICU Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICU Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICU Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
ICU Medical is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
ICU Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ICU Medical stock to make a market-neutral strategy. Peer analysis of ICU Medical could also be used in its relative valuation, which is a method of valuing ICU Medical by comparing valuation metrics with similar companies.
Peers
ICU Medical Related Equities
| XRAY | Dentsply Sirona | 3.00 | ||||
| MMSI | Merit Medical | 0.47 | ||||
| ATR | AptarGroup | 0.80 | ||||
| HAE | Haemonetics | 1.12 | ||||
| NVST | Envista Holdings | 1.28 | ||||
| COO | Cooper Companies, | 1.98 | ||||
| ANGO | AngioDynamics | 2.00 | ||||
| HOLX | Hologic | 2.07 | ||||
| ATRC | AtriCure | 2.46 | ||||
| AKYA | Akoya Biosciences | 2.49 |
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |